Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin

Clinical Characteristics and Metabolic Predictors of Rapid Responders to Dipeptidyl Peptidase-4 Inhibitor as an Add-on Therapy to Sulfonylurea and Metformin

BackgroundDipeptidyl peptidase-4 (DPP-4) inhibitor add-on therapy is a new option for patients with inadequately controlled type 2 diabetes who are taking combined metformin and sulfonylurea (SU). We evaluated the efficacy and safety of this triple therapy and the characteristics of rapid responders...

Full description

Bibliographic Details
Main Authors: Ye An Kim, Won Sang Yoo, Eun Shil Hong, Eu Jeong Ku, Kyeong Seon Park, Soo Lim, Young Min Cho, Kyong Soo Park, Hak Chul Jang, Sung Hee Choi
Format: Article
Language:English
Published: Korean Diabetes Association 2015-12-01
Series:Diabetes & Metabolism Journal
Subjects:
Combination
Diabetes mellitus, type 2
Dipeptidyl-peptidase IV inhibitors
Hypoglycemia
Response
Sulfonylurea compounds
Online Access:http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-489.pdf

Internet

http://e-dmj.org/Synapse/Data/PDFData/2004DMJ/dmj-39-489.pdf

Similar Items